, Volume 95, Issue 1, pp 19–24

Psychomotor stimulant effects of methylxanthines in squirrel monkeys: relation to adenosine antagonism

  • R. D. Spealman
Original Investigations


The behavioral effects of six methylxanthines were studied in squirrel monkeys responding under a fixed-interval (FI) schedule of stimulus-shock termination. Dose-response curves were determined for each drug by administering cumulative doses IV during timeout periods that preceded sequential components of the FI schedule. Low to intermediate doses of caffeine, theophylline, 8-phenyltheophylline (8-PT), 8-cyclopentyltheophylline (CPT), and 3-isobutyl-1-methylxanthine (IBMX) produced dose-related increases in response rate, whereas higher doses increased response rate less or decreased it. Enprofylline did not increase response rate at any dose. Pretreatment with a high dose of the adenosine agonist 5′-N-ethylcarboxamide adenosine (NECA) suppressed responding throughout the experimental session. Caffeine, theophylline, 8-PT, CPT, and IBMX, but not enprofylline, antagonized the suppressant effects of NECA in a dose-related manner. The potencies of the methylxanthines for increasing response rate under the FI schedule were positively correlated with their potencies for antagonizing the suppressant effects of NECA, suggesting that the psychomotor stimulant effects of methylxanthines are linked to their antagonistic actions at adenosine recognition sites. CPT, which in vitro has much higher affinity (>103-fold) than caffeine for adenosine A1, but not for A2, recognition sites, was only 3–6 times more potent than caffeine in increasing response rate or in antagonizing the effects of NECA. The psychomotor stimulant effects of methylxanthines therefore appear to be more closely associated with antagonism at adenosine A2 than adenosine A1 recognition sites.

Key words

Methylxanthines Behavioral effects Adenosine antagonists Squirrel monkeys 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bergstrand H (1985) Xanthines as phosphodiesterase inhibitors. In: Andersson K-E, Persson CGA (eds) Antiasthma xanthines and adenosine. Excerpta Medica, Amsterdam, pp 16–20Google Scholar
  2. Bruns RF, Daly JW, Snyder SH (1980) Adenosine receptors in brain membranes: binding of N6-cyclohexyl[3H] adenosine and 1,3-diethyl-8-[3H]-phenylxanthine. Proc Natl Acad Sci USA 77:5547–5551Google Scholar
  3. Bruns RF, Lu GH, Pugsley TA (1985) Towards selective adenosine antagonists. In: Stefanovich V, Rudolphi K, Schubert P (eds) Adenosine: receptors and modulation of cell functions. IRL Press, Oxford, pp 51–58Google Scholar
  4. Bruns RF, Lu GH, Pugsley TA (1986) Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes. Mol Pharmacol 29:331–346Google Scholar
  5. Carney JM (1982) Effects of caffeine, theophylline and theobromine on schedule-controlled responding in rats. Br J Pharmacol 75:451–454Google Scholar
  6. Coffin VL, Spealman RD (1987) Behavioral and cardiovascular effects of analogs of adenosine in cynomolgus monkeys. J Pharmacol Exp Ther 241:76–83Google Scholar
  7. Coffin VL, Taylor JA, Phillis JW, Altman HJ, Barraco RA (1984) Behavioral interaction of adenosine and methylxanthines on central purinergic systems. Neurosci Lett 47:91–98Google Scholar
  8. Daly JW (1982) Adenosine receptors: targets for future drugs. J Med Chem 25:197–207Google Scholar
  9. Fredholm BB (1980) Are methylxanthine effects due to antagonism of endogenous adenosine? TIPS 5:129–132Google Scholar
  10. Fredholm BB, Persson CG (1982) Xanthine derivatives as adenosine receptor antagonists. Eur J Pharmacol 81:673–676Google Scholar
  11. Glowa JR, Spealman RD (1984) Behavioral effects of caffeine, N6-(l-phenylisopropyl) adenosine and their combination in the squirrel monkey. J Pharmacol Exp Ther 231:665–670Google Scholar
  12. Graham DM (1978) Caffeine — its identity, dietary sources, intake and biological effects. Nutr Rev 36:97–102Google Scholar
  13. Herd JA, Morse WH, Kelleher RT, Jones LG (1969) Arterial hypertension in the squirrel monkey during behavioral experiments. Am J Physiol 217:24–29Google Scholar
  14. Katims JJ, Annau Z, Snyder SH (1983) Interactions in the behavioral effects of methylxanthines and adenosine derivatives. J Pharmacol Exp Ther 277:267–173Google Scholar
  15. Logan L, Carney JM (1984) Antagonism of the behavioral effects of l-phenylisopropyladenosine (l-PIA) by caffeine and its metabolites. Pharmacol Biochem Behav 21:375–379Google Scholar
  16. Londos C, Cooper DMF, Wolff J (1980) Subclasses of adenosine receptors. Proc Natl Acad Sci USA 77:2251–2254Google Scholar
  17. Persson CGA, Andersson K-E, Kjellin G (1986) Effects of enprofylline and theophylline may show role of adenosine. Life Sci 38:1057–1072Google Scholar
  18. Rall TW (1982) Evolution of the mechanisms of action of methylxanthines: from calcium mobilizers to antagonists of adenosine receptors. Pharmacologist 24:277–287Google Scholar
  19. Scotini E, Carpenedo F, Fassina G (1983) New derivatives of methylxanthines: effect of thiocaffeine, thiotheophylline and 8-phenyltheophylline on lipolysis and on phosphodiesterase activities. Pharmacol Res Commun 15:131–143Google Scholar
  20. Smellie FW, Davis CW, Daly JW, Wells JN (1979) Alkylxanthines: inhibition of adenosine-elicited accumulation of cyclic AMP in brain slices and of brain phosphodiesterase activity. Life Sci 24:2475–2482Google Scholar
  21. Snyder SH, Katims JJ, Annau Z, Bruns RF, Daly JW (1981) Adenosine receptors and the behavioral actions of methylxanthines. Proc Natl Acad Sci USA 78:3260–3264Google Scholar
  22. Spealman RD, Coffin VL (1986) Behavioral effects of adenosine analogs in squirrel monkeys: relation to adenosine A2 receptors. Psychopharmacology 90:419–421Google Scholar
  23. Spealman RD, Goldberg SR, Kelleher RT, Goldberg DM, Charlton JP (1977) Some effects of cocaine and two cocaine analogs on schedule-controlled behavior of squirrel monkeys. J Pharmacol Exp Ther 202:500–509Google Scholar
  24. Van Calker D, Muller M, Hamprecht B (1979) Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J Neurochem 33:999–1005Google Scholar

Copyright information

© Springer-Verlag 1988

Authors and Affiliations

  • R. D. Spealman
    • 1
  1. 1.Harvard Medical SchoolNew England Regional Primate Research CenterSouthboroughUSA

Personalised recommendations